Novel and Emerging Treatment Strategies for Advanced Classical Hodgkin Lymphoma

To claim credit visit https://i3health.com/ODA-HL Hodgkin lymphoma is a rare malignancy that originates in the lymphatic system. Management challenges include the need to improve outcomes in advanced disease and optimize treatment tolerability in both younger and older patients. This episode of Oncology Data Advisor will focus on novel and emerging treatment strategies for advanced classical Hodgkin lymphoma. It features perspectives from two noted experts in the field: Dr. Kami Maddocks, Professor of Clinical Internal Medicine and Lymphoma Program Director at The James Cancer Hospital of The Ohio State University; and Dr. Kelly Brassil, Lead Care Manager at The University of Texas MD Anderson Cancer Center. This activity is supported by an independent educational grant from Seagen. Free CME and NCPD credit are available for this podcast. To obtain further information and claim credit, visit i3Health.com/ODA-HL.